Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin (Q38244345)

31 August 2017

Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin (English)

1 reference

31 August 2017

1 reference

Joseph Najbauer

1

1 reference

31 August 2017

Nikola Kraljik

series ordinal

2

1 reference

31 August 2017

Péter Németh

series ordinal

3

1 reference

31 August 2017

29 August 2014

1 reference

Pathology Oncology Research

31 August 2017

1 reference

31 August 2017

20

1 reference

31 August 2017

4

1 reference

31 August 2017

789-797

1 reference

https://scigraph.springernature.com/pub.10.1007/s12253-014-9837-z

31 August 2017

0 references

cites work

Malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

The neurobiology of gliomas: from cell biology to the development of therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Drug penetration in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Engaging neuroscience to advance translational research in brain barrier biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Cells of origin in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Cancer stem cells: current status and evolving complexities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Targeting glioma stem cells: a novel framework for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Brain cancer stem cells: current status on glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

21 January 2018

Brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Chemotherapy resistance of glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Cancer stem cells in nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Repositioning metformin for cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin and cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin--mode of action and clinical implications for diabetes and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

The blooming of the French lilac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Diabetes, metformin, and breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Epigenetic pathways and glioblastoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Cellular host responses to gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Glioblastoma multiforme stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

The brain tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin and cancer: new applications for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin: multi-faceted protection against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9837-Z

Opinion: the origin of the cancer stem cell: current controversies and new insights

21 January 2018

1 reference

12 December 2020

Cancer stem cells: an evolving concept

1 reference

12 December 2020

FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.

1 reference

12 December 2020

The insulin and insulin-like growth factor receptor family in neoplasia: an update

1 reference

12 December 2020

Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy

1 reference

12 December 2020

Strategies for enhancing antibody delivery to the brain

1 reference

12 December 2020

10.1007/S12253-014-9837-Z

Identifiers

DOI

1 reference

release_ai53sdtlvjfadl5ajfdvy6rxu4

31 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ai53sdtlvjfadl5ajfdvy6rxu4

24 November 2022

mapped directly with Wikidata item

1 reference